Two-year results of intravitreal ranibizumab for polypoidal choroidal vasculopathy with recurrent or residual exudation.
about
Two-year results of intravitreal ranibizumab for polypoidal choroidal vasculopathy with recurrent or residual exudation.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Two-year results of intravitre ...... current or residual exudation.
@en
Two-year results of intravitre ...... current or residual exudation.
@nl
type
label
Two-year results of intravitre ...... current or residual exudation.
@en
Two-year results of intravitre ...... current or residual exudation.
@nl
prefLabel
Two-year results of intravitre ...... current or residual exudation.
@en
Two-year results of intravitre ...... current or residual exudation.
@nl
P2093
P2860
P356
P1433
P1476
Two-year results of intravitre ...... current or residual exudation.
@en
P2093
P2860
P2888
P304
P356
10.1038/EYE.2013.114
P577
2013-06-07T00:00:00Z